Hua Yang
Chongqing University(CN)China Pharmaceutical University(CN)Chinese Academy of Sciences(CN)China Spallation Neutron Source(CN)Hunan Academy of Agricultural Sciences(CN)Deyang Stomatological Hospital(CN)Affiliated Hospital of Hebei University(CN)Yueyang Changling Equipment Research Institute (China)(CN)First People's Hospital of Chongqing(CN)Spallation Neutron SourceState Key Laboratory of Natural Medicine
Publications by Year
Research Areas
Traditional Chinese Medicine Analysis, Metabolomics and Mass Spectrometry Studies, Acute Myeloid Leukemia Research, Cancer, Hypoxia, and Metabolism, Ginkgo biloba and Cashew Applications
Most-Cited Works
- → Durable Remissions with Ivosidenib in IDH1 -Mutated Relapsed or Refractory AML(2018)1,382 cited
- → An Inhibitor of Mutant IDH1 Delays Growth and Promotes Differentiation of Glioma Cells(2013)1,144 cited
- → Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis(2012)816 cited
- → Targeted Inhibition of Mutant IDH2 in Leukemia Cells Induces Cellular Differentiation(2013)791 cited
- → AG-221, a First-in-Class Therapy Targeting Acute Myeloid Leukemia Harboring Oncogenic IDH2 Mutations(2017)450 cited
- → Discovery of AG-120 (Ivosidenib): A First-in-Class Mutant IDH1 Inhibitor for the Treatment of IDH1 Mutant Cancers(2018)430 cited